SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Martek Biosciences Corp – ‘8-K’ for 4/8/03

On:  Tuesday, 4/8/03, at 5:14pm ET   ·   For:  4/8/03   ·   Accession #:  950133-3-1255   ·   File #:  0-22354

Previous ‘8-K’:  ‘8-K/A’ on 4/1/03 for 4/25/02   ·   Next:  ‘8-K’ on / for 6/3/03   ·   Latest:  ‘8-K’ on 2/25/11 for 2/18/11

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 4/08/03  Martek Biosciences Corp           8-K:5,7     4/08/03    2:16K                                    Bowne - DC/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     12K 
 2: EX-99.1     Press Release                                       HTML      8K 


8-K   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



  e8vk  

 



UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 8, 2003

Martek Biosciences Corporation
(Exact Name of Registrant as Specified in its
Charter)

         
Delaware   000-22354   52-1399362

 
(State or Other Jurisdiction of   (Commission File   (IRS Employer
Incorporation)   Number)   Identification No.)
         
6480 Dobbin Road    Columbia, Maryland       21045

(Address of Principal Executive Offices)       (Zip Code)

Registrant’s telephone number, including area code: (410) 740-0081


(Former Name or Former Address, if Changed Since Last Report)





 

MARTEK BIOSCIENCES CORPORATION

Item 5.             Other Events and Required FD Disclosure.

                          Martek announced today that it had received a report from the Office of the Kentucky State Fire Marshal regarding the wastewater pretreatment facility explosion that occurred in March, 2003. Martek’s press release which describes the findings of the report is attached hereto as Exhibit 99.1 and is incorporated herein by this reference.

Item 7.             Financial Statements, Pro Forma Financial Information and Exhibits

  (c)     Exhibits.

  The following is filed as an exhibit to this current report on Form 8-K:
 
  99.1  Press Release dated April 8, 2003. (filed herewith)

-2-



 

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    MARTEK BIOSCIENCES CORPORATION  
 
Date: April 8, 2003   By: /s/ George P. Barker

George P. Barker
Senior Vice President and
General Counsel
 

-3-



 

INDEX TO EXHIBITS

     
Exhibit    
Number    
     
99.1   Press Release dated April 8, 2003. (filed herewith)

-4-


Dates Referenced Herein

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period End:4/8/03None on these Dates
 List all Filings 
Top
Filing Submission 0000950133-03-001255   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 26, 1:13:01.1pm ET